AERI
Neuberger Berman Group’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-552,400
| Closed | -$16.3M | – | 1613 |
|
|
2019
Q2 | $16.3M | Buy |
552,400
+158,900
| +40% | +$4.7M | 0.02% | 654 |
|
|
2019
Q1 | $18.7M | Buy |
393,500
+7,000
| +2% | +$332K | 0.02% | 621 |
|
|
2018
Q4 | $14M | Buy |
386,500
+10,700
| +3% | +$386K | 0.02% | 661 |
|
|
2018
Q3 | $23.1M | Buy |
375,800
+34,500
| +10% | +$2.12M | 0.03% | 602 |
|
|
2018
Q2 | $23.1M | Buy |
341,300
+20,800
| +6% | +$1.41M | 0.03% | 607 |
|
|
2018
Q1 | $17.4M | Buy |
320,500
+59,000
| +23% | +$3.2M | 0.02% | 658 |
|
|
2017
Q4 | $15.6M | Buy |
261,500
+236,500
| +946% | +$14.1M | 0.02% | 693 |
|
|
2017
Q3 | $1.22M | Buy |
25,000
+12,500
| +100% | +$608K | ﹤0.01% | 1092 |
|
|
2017
Q2 | $657K | Buy |
+12,500
| New | +$657K | ﹤0.01% | 1241 |
|
|
2017
Q1 | – | Sell |
-11,500
| Closed | -$435K | – | 1646 |
|
|
2016
Q4 | $435K | Sell |
11,500
-7,000
| -38% | -$265K | ﹤0.01% | 1312 |
|
|
2016
Q3 | $698K | Buy |
+18,500
| New | +$698K | ﹤0.01% | 1186 |
|
|
2015
Q1 | – | Sell |
-27,500
| Closed | -$802K | – | 1670 |
|
|
2014
Q4 | $802K | Buy |
+27,500
| New | +$802K | ﹤0.01% | 1264 |
|